C. H. ROBINSON WORLDWIDE, INC.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $CHRW in the last 30 days.
See all $CHRW insider activity →BMO Capital's Fadi Chamoun maintained a Hold rating and $160 price target for CH Robinson (CHRW). Deutsche Bank also issued a Hold, while Raymond James kept a Buy rating. CH Robinson reported Q2 revenue of $4.93B and net profit of $186.79M, up from $4.14B and $152.47M last year.
A Texas judge affirmed a $604 million judgment against C.H. Robinson (CHRW) for a 2021 fatal accident. The case, Lipe vs. Lupus Superior, raises concerns for the company due to the verdict size and jury findings on control. CHRW had $5.8 billion in Q2 assets, including $154.9 million in cash.
C.H. Robinson (CHRW) is appealing a $604M judgment in the Lipe v. Lupus Superior case, which held it liable for a 2021 accident. The company argues it followed federal safety standards and did not employ the driver. It calls for a national carrier-safety standard, citing potential market impacts on trucking companies, brokers, and supply chains.
Over the past 7 days, AlphAI's AI scored 14 news stories mentioning CHRW (C. H. ROBINSON WORLDWIDE, INC.). Coverage has skewed bearish: 5 bullish, 3 neutral, and 6 bearish.
Recent CHRW coverage spans financial news, regulation and sector analysis.
Analyst hold rating with unchanged target likely exerts neutral to slight downside pressure.
The affirmed verdict introduces a significant financial burden and potential credit rating pressure for C.H. Robinson.
The $604 M liability judgment introduces significant financial and regulatory risk for CHRW.
Street caution on the RXO deal is likely to keep CHRW under pressure until integration and leverage concerns are clarified.
Analyst price target cut suggests near‑term downside pressure on CHRW.
AlphAI scores every news story that mentions CHRW with an AI model for sentiment and relevance, and aggregates insider trades from C. H. ROBINSON WORLDWIDE, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
BMO Capital's Fadi Chamoun maintained a Hold rating and $160 price target for CH Robinson (CHRW). Deutsche Bank also issued a Hold, while Raymond James kept a Buy rating. CH Robinson reported Q2 revenue of $4.93B and net profit of $186.79M, up from $4.14B and $152.47M last year.
1 min readA Texas judge affirmed a $604 million judgment against C.H. Robinson (CHRW) for a 2021 fatal accident. The case, Lipe vs. Lupus Superior, raises concerns for the company due to the verdict size and jury findings on control. CHRW had $5.8 billion in Q2 assets, including $154.9 million in cash.
2 min readC.H. Robinson (CHRW) is appealing a $604M judgment in the Lipe v. Lupus Superior case, which held it liable for a 2021 accident. The company argues it followed federal safety standards and did not employ the driver. It calls for a national carrier-safety standard, citing potential market impacts on trucking companies, brokers, and supply chains.
2 min readC.H. Robinson's stock fell as analysts lowered price targets due to concerns over its RXO acquisition, which may increase leverage and integration risks. While the company aims to improve productivity, its debt load and freight market exposure pose risks. YTD performance is -9.54%, with a market cap of $16.1B.
3 min readBMO Capital reduced its price target for C.H. Robinson (CHRW) to $160 from $190, citing integration risks from its RXO acquisition. The stock trades at $144.91, with 15 analysts raising earnings estimates. BMO sees 15% upside at through-the-cycle earnings. Other analysts have mixed views on the deal.
2 min readC H Robinson Worldwide discusses the evolving landscape of customs enforcement, highlighting increased importer accountability, supply chain visibility, and data-driven enforcement by U.S. Customs and Border Protection (CBP). Key changes include stricter importer identity validation, higher bond requirements, and expanded enforcement actions. The company advises importers to proactively prepare for these changes to minimize compliance risks.
5 min readArgus raised its price target for C.H. Robinson (CHRW) to $131.00. The company is a leading non-asset-based logistics provider, with 60% of revenue from domestic freight brokerage, primarily truck brokerage.
1 min readTRAFFIX executives report North American cross-border trucking capacity will remain constrained until 2027 due to driver shortages, regulatory hurdles, and higher financing costs. The company's October index shows tight market conditions in Canada (57) and Mexico (54). Challenges include U.S. visa restrictions for Mexican drivers and imbalanced freight flows in Canada, leading to higher rates and increased spot market activity.
3 min readDeutsche Bank downgraded C.H. Robinson, citing uncertainty around its RXO deal integration. While long-term cost savings of $300 million are noted, higher leverage may cap upside until progress is shown. Investors await proof of integration success and debt reduction.
2 min readC.H. Robinson (CHRW) will acquire RXO (RXO) in a $5.8B deal, valuing RXO at $30.25 per share, a 29% premium. The combined entity will have an enterprise value of over $25B. RXO shareholders will receive cash and stock, with the deal expected to close in H1 2027. CHRW projects $300M in annual cost synergies.
4 min read
